Gelonghui, February 2, 丨 Nanxin Pharmaceutical (688189.SH) announced that as of January 31, 2024, the company had repurchased 246,709 shares of the company's shares through centralized bidding transactions, accounting for 0.0899% of the company's total share capital of 274,400,000 shares. The highest price of the repurchase transaction was 9.24 yuan/share, the lowest price was 7.30 yuan/share, and the total amount of capital paid was RMB 1,999,602.58 (excluding transaction fees such as stamp duty and transaction fees).
南新制药(688189.SH)：截至1月31日已累计回购24.67万股
Nanxin Pharmaceutical (688189.SH): A total of 246,700 shares have been repurchased as of January 31
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.